Skip to main content
. Author manuscript; available in PMC: 2020 Sep 29.
Published in final edited form as: Int J Cancer. 2019 Oct 8;146(11):2987–2998. doi: 10.1002/ijc.32653

Table 1.

SNPs demonstrating genome-wide suggestive evidence of association in the African Ancestry OncoArray Analysis and comparison with results of OCAC studies of women of European ancestry

Subtype Nearest gene SNP ID (effect/other allele) Build 37 Chr:Pos African ancestry2 European ancestry3
EAF OR (95% CI) p Value BFDP4 EAF OR (95% CI) p Value
EOC AKR1C3 rs4525119 (T/C) 10:5091954 0.331 0.70 (0.61–0.81) 4.9 × 10−7 8% 0.300 1.00 (0.97–1.03) 0.936
LOC101927394 TS76434591 (T/G) 3:8004828 0.362 1.40 (1.22–1.60) 8.4 × 10−7 5% 0.421 1.00 (0.98–1.03) 0.742
UGT2A2 rs4286604 (A/G) 4:70442165 0.268 0.69 (0.59–0.80) 8.5 × 10−7 5% 0.227 1.01 (0.98–1.05) 0.421
WWC1 rsl42091544 (T/C) 5:167714000 0.034 3.22 (2.02–5.13) 9.4 × 10−7 9% 0.010 0.97 (0.83–1.13) 0.665
HGSOC FST rs37792 (G/A) 5:52644647 0.342 0.65 (0.55–0.76) 6.0 × 10−8 <1% 0.308 1.03 (0.99–1.06) 0.110
MAGEC1 rs57403204 (G/A) X:141078552 0.064 2.62 (1.83–3.76) 1.7 × 10−7 1% 0.013 1.03 (0.90–1.18) 0.682
LOCW5376360 rs79079890 (G/T) 10:3684148 0.032 3.20 (2.05–4.99) 3.0 × 10−7 3% 0.131 1.02 (0.98–1.08) 0.534
PRPSAP1 rs66459581 (A/AC) 17:74355264 0.234 1.63 (1.35–1.97) 5.1 × 10−7 2% 0.089 0.97 (0.92–1.03) 0.377
GABRG3 rsll6046250 (G/T) 15:27231950 0.046 2.95 (1.92–4.54) 8.7 × 10−7 7%
LQC105377300/GK2 rsl92876988 (C/T) 4:80297251 0.046 3.01 (1.94–4.68) 9.2 × 10−7 8% 0.014 0.75 (0.62–0.90) 0.002

We show the strongest associated SNP for each locus reaching p < 1 × 10−6 for each subtype.

1

Genotyped SNPs, if not indicated otherwise then imputed.

2

African ancestry was defined as >50% African ancestry as calculated by FastPop.

3

European ancestry was defined by self-report.

4

Bayesian false discovery probability (BFDP) assuming a prior of 1:1,000 among women of African ancestry.

Abbreviations: CI, confidence interval; EAF, effect allele frequency; EOC, epithelial ovarian cancer; HGSOC, high-grade serous ovarian carcinoma; OR, odds ratio; SNP, single nucleotide polymorphism.